[Pharmacotherapy of intestinal dysbacteriosis].
作者信息
Chekman I S
出版信息
Lik Sprava. 2000 Oct-Dec(7-8):6-11.
PMID:16786636
Abstract
The article presents a summary of the published literature together with results of the author's own investigations designed to study pharmacotherapy of intestinal dysbacteriosis. Reasons for the origination of the above medical condition are given, the particulars of its clinical presentation are specified. Clinical-and-pharmacological properties of chylac forte, a new effective probiotic, are detailed.
摘要
相似文献
1
[Pharmacotherapy of intestinal dysbacteriosis].
Lik Sprava. 2000 Oct-Dec(7-8):6-11.
2
[Adequate therapy of intestinal dysbacteriosis in children].
Klin Med (Mosk). 1998;76(10):35-8.
3
[Pharmacological study of herbal preparation for complex treatment of intestine dysbacteriosis].
Eksp Klin Gastroenterol. 2007(5):68-70.
4
[Treatment of intestinal dysbacteriosis in children with diabetes mellitus].
Antibiot Khimioter. 1999;44(3):22-4.
5
[Dysbacteriosis in enteropathies].
Med Interne. 1980 Jul-Sep;18(3):239-45.
6
[Prevention of intestinal dysbiosis in patients after anti-Helicobacter therapy].
Eksp Klin Gastroenterol. 2009(8):108-11.
7
[The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
Vestn Ross Akad Med Nauk. 2004(2):13-7.
8
[The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
Zh Mikrobiol Epidemiol Immunobiol. 1995 Mar-Apr(2):101-4.
9
10
[Probiotic strains of enterococci as a means of therapy and prophylaxis of intestinal diseases in children (review of literature)].
Eksp Klin Gastroenterol. 2013(1):74-8.
Zotero 插件